NPIL Pharma offers a comprehensive range of services to support pre-clinical and early clinical development of new pharmaceutical products. NPIL Pharma can provide advanced intermediates and active pharmaceuticals, at laboratory, kilogram and pilot plant scale and can also manufacture formulations batches for clinical studies
NPIL Pharma technologists are experts at chemical process invention, selection, development and implementation. In addition, capabilities include a complete range of support services, from advanced analytical method development and validation to product stability studies and regulatory submission.
PDS API development services are offered through centers at Torcan (Canada), EPDT (UK), Morpeth (UK) and PDG (India)
PDS Formulations development services are offered through centres at PR&D (India) and Morpeth (UK)